Cetrotide

Drug

Drug Profile

Cetrotide is the brand name for cetrorelix acetate, an injectable GnRH antagonist used in assisted reproduction. It is used during IVF cycles to prevent premature LH surges and untimely ovulation before planned trigger administration. It is a prescription medication.

Drug Class
GnRH antagonist; antigonadotropin
Approval Status
Prescription-only in major regions including the US and EU
Mechanism of Action
Blocks GnRH action at the pituitary, rapidly suppressing LH and FSH production and action
Brand Names
  • Cetrotide
Indications
  • \Prevention of premature luteinizing hormone surge during controlled ovarian stimulation in IVF/assisted reproduction\

Related News

TrumpRx Platform Launches With Mixed Savings on Prescription Drugs

The Trump administration launched TrumpRx.gov in February 2026, offering discounted prices on dozens of brand-name prescription drugs through negotiated deals with pharmaceutical companies, though critics warn many listed drugs have cheaper generic alternatives.

Related Clinical Trials

NCT ID Title Status Phase
NCT05751681

Dydrogesterone-Primed Ovarian Stimulation Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in ICSI

UNKNOWN NA
NCT04671966

Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction

RECRUITING PHASE4
NCT04308343

The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy

UNKNOWN NA
NCT02333253

Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase

COMPLETED PHASE3
NCT02042196

Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women

COMPLETED EARLY_PHASE1
NCT01109888

Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS)

WITHDRAWN PHASE1/PHASE2
NCT00439829

Synchronization of Follicle Wave Emergence and Ovarian Stimulation

COMPLETED PHASE4